Skip to main content
Top
Published in: Rheumatology International 12/2014

01-12-2014 | Original Article

Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature

Authors: Hang Liu, Gejun Zhang, Yimeng Niu, Nan Jiang, Weiguo Xiao

Published in: Rheumatology International | Issue 12/2014

Login to get access

Abstract

The purpose of the study was to investigate the clinical features and outcomes of retroperitoneal fibrosis (RPF). Fifty-eight RPF treatment cases in the First Affiliated Hospital of China Medical University were retrospectively analyzed, including clinical characteristics and laboratory data. RPF was found predominantly in elderly men with atypical clinical manifestations of back pain, abdominal pain, and lower limb edemas. In laboratory examinations, the acute-phase reactants such as erythrocyte sedimentation rate and C-reactive protein levels increased significantly. Renal function failure was frequently found in patients with urethral obstruction. All patients had retroperitoneal soft tissue shadows or urethral obstructions on computed tomography (CT) or magnetic resonance imaging (MRI), seven of which had histological diagnosis of idiopathic RPF. Forty-two patients received surgical interventions; 29 patients received medication treatment alone including corticosteroids, immunosuppressants, and tamoxifen; 17 patients received corticosteroids after surgical intervention. Surgery followed by medication was most effective for RPF. CT and MRI help to exclude secondary causes, but biopsy remains the gold standard for diagnosis. Long-term low-dose corticosteroids and immunosuppressants may prevent relapse of RPF.
Literature
2.
go back to reference Albarran J (1905) Retention renale par peri-ureterite: liberation externe de l’uretere. Assoc Fr Urol 9:511–517 Albarran J (1905) Retention renale par peri-ureterite: liberation externe de l’uretere. Assoc Fr Urol 9:511–517
3.
go back to reference Ormond JK (1948) Bilateral ureteral obstruction due to envelopment and compression by an inflammatory process. J Urol 59:1072–1079PubMed Ormond JK (1948) Bilateral ureteral obstruction due to envelopment and compression by an inflammatory process. J Urol 59:1072–1079PubMed
4.
go back to reference Vaglio A, Buzio C (2005) Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 17:34–40PubMedCrossRef Vaglio A, Buzio C (2005) Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 17:34–40PubMedCrossRef
5.
go back to reference Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis: a true connective tissue disease. Rheum Dis Clin North Am 22:23–38PubMedCrossRef Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis: a true connective tissue disease. Rheum Dis Clin North Am 22:23–38PubMedCrossRef
6.
go back to reference Van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL (2009) Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 88(4):193–201CrossRef Van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL (2009) Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 88(4):193–201CrossRef
7.
go back to reference Li Kun-Peng, Zhu Jian, Zhang Jiang-Lin, Huang Feng (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30:601–605PubMedCrossRef Li Kun-Peng, Zhu Jian, Zhang Jiang-Lin, Huang Feng (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30:601–605PubMedCrossRef
8.
go back to reference Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C (2007) Retroperitonealfibrosis: evolving concepts. Rheum Dis Clin North Am 33:803–817PubMedCrossRef Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C (2007) Retroperitonealfibrosis: evolving concepts. Rheum Dis Clin North Am 33:803–817PubMedCrossRef
9.
go back to reference Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L et al (2007) Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 72(6):742–753PubMedCrossRef Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L et al (2007) Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 72(6):742–753PubMedCrossRef
10.
go back to reference Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C et al (2006) Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin [J]. Arthritis Rheum 55(1):126–130PubMedCrossRef Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C et al (2006) Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin [J]. Arthritis Rheum 55(1):126–130PubMedCrossRef
11.
go back to reference Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C (2003) Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114(6):454–462PubMedCrossRef Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C (2003) Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114(6):454–462PubMedCrossRef
12.
go back to reference Vaglio A (2009) Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine (Bal-timore) 88(4):208–210CrossRef Vaglio A (2009) Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine (Bal-timore) 88(4):208–210CrossRef
13.
go back to reference Kottra JJ, Dunnick NR (1996) Retroperitoneal fibrosis. Radiol Clin North Am 34(6):1259–1275PubMed Kottra JJ, Dunnick NR (1996) Retroperitoneal fibrosis. Radiol Clin North Am 34(6):1259–1275PubMed
14.
go back to reference Baker LR, Mallinson WJ, Gregory MC, Menzies EA, Cattell WR, Whitfield HN et al (1987) Idiopathic retroperitoneal fibrosis: a retrospective analysis of 60 cases [J]. Br J Urol 60(6):497–503PubMedCrossRef Baker LR, Mallinson WJ, Gregory MC, Menzies EA, Cattell WR, Whitfield HN et al (1987) Idiopathic retroperitoneal fibrosis: a retrospective analysis of 60 cases [J]. Br J Urol 60(6):497–503PubMedCrossRef
15.
go back to reference Khosroshahi A, Stone JH (2011) A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 23(1):57–66PubMedCrossRef Khosroshahi A, Stone JH (2011) A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 23(1):57–66PubMedCrossRef
16.
go back to reference Van Moerkercke W, Verhamme M, Doubel P, Meeus G, Oyen R, Van Steenbergen W (2010) Autoimmune pancreatitis and extrapancreatic manifestations of IgG4-related sclerosing disease. Acta Gastroenterol Belg 73:239–246PubMed Van Moerkercke W, Verhamme M, Doubel P, Meeus G, Oyen R, Van Steenbergen W (2010) Autoimmune pancreatitis and extrapancreatic manifestations of IgG4-related sclerosing disease. Acta Gastroenterol Belg 73:239–246PubMed
17.
go back to reference Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1–14PubMedCentralPubMedCrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1–14PubMedCentralPubMedCrossRef
19.
go back to reference Lepor H, Walsh PC (1979) Idiopathic retroperitoneal fibrosis. J Urol 122(1):1–6PubMed Lepor H, Walsh PC (1979) Idiopathic retroperitoneal fibrosis. J Urol 122(1):1–6PubMed
20.
go back to reference Seth A, Ansari MS, Trikha V, Mittal R (2001) Retroperitoneal fibrosis: a rare complication of Pott’s disease. J Urol 166:622–623PubMedCrossRef Seth A, Ansari MS, Trikha V, Mittal R (2001) Retroperitoneal fibrosis: a rare complication of Pott’s disease. J Urol 166:622–623PubMedCrossRef
21.
go back to reference Milam MR, Schultenover SJ, Crispens M, Parker L (2004) Retroperitoneal fibrosis secondary to actinomycosis with no intrauterine device. Obstet Gynecol 104:1134–1136PubMedCrossRef Milam MR, Schultenover SJ, Crispens M, Parker L (2004) Retroperitoneal fibrosis secondary to actinomycosis with no intrauterine device. Obstet Gynecol 104:1134–1136PubMedCrossRef
22.
go back to reference Moul JW (1992) Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma. J Urol 147:124–126PubMed Moul JW (1992) Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma. J Urol 147:124–126PubMed
23.
go back to reference Hoekstra HJ, Restrepo C, Kinsella TJ, Sindelar WF (1998) Histopathological effects of intraoperative radiotherapy on pancreas and adjacent tissues: a postmortem analysis. J Surg Oncol 37:104–108CrossRef Hoekstra HJ, Restrepo C, Kinsella TJ, Sindelar WF (1998) Histopathological effects of intraoperative radiotherapy on pancreas and adjacent tissues: a postmortem analysis. J Surg Oncol 37:104–108CrossRef
24.
go back to reference Rabbani F, Farivar-Mohseni H, Leon A, Motzer RJ, Bosl GJ, Sheinfeld J (2003) Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma. Urology 62:1092–1096PubMedCrossRef Rabbani F, Farivar-Mohseni H, Leon A, Motzer RJ, Bosl GJ, Sheinfeld J (2003) Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma. Urology 62:1092–1096PubMedCrossRef
25.
go back to reference Serratrice J, Granel B, De Roux C, Pellissier JF, Swiader L, Bartoli JM et al (2000) “Coated aorta”: a new sign of Erdheim-Chester disease. J Rheumatol 27:1550–1553PubMed Serratrice J, Granel B, De Roux C, Pellissier JF, Swiader L, Bartoli JM et al (2000) “Coated aorta”: a new sign of Erdheim-Chester disease. J Rheumatol 27:1550–1553PubMed
26.
go back to reference Uibu T, Oksa P, Auvinen A, Honkanen E, Metsärinne K, Saha H et al (2004) Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 363(9419):1422–1426PubMedCrossRef Uibu T, Oksa P, Auvinen A, Honkanen E, Metsärinne K, Saha H et al (2004) Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 363(9419):1422–1426PubMedCrossRef
27.
go back to reference Magrey MN, Husni ME, Kushner I, Calabrese LH (2009) Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 61(5):674–679PubMedCrossRef Magrey MN, Husni ME, Kushner I, Calabrese LH (2009) Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 61(5):674–679PubMedCrossRef
28.
go back to reference Vivas I, Nicolás AI, Velázquez P, Elduayen B, Fernández-Villa T, Martínez-Cuesta A (2000) Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol 73:214–222PubMedCrossRef Vivas I, Nicolás AI, Velázquez P, Elduayen B, Fernández-Villa T, Martínez-Cuesta A (2000) Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol 73:214–222PubMedCrossRef
29.
go back to reference Arrivé L, Hricak H, Tavares NJ, Miller TR (1989) Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging. Radiology 172:139–143PubMedCrossRef Arrivé L, Hricak H, Tavares NJ, Miller TR (1989) Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging. Radiology 172:139–143PubMedCrossRef
30.
go back to reference Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN (2013) Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics 33(2):535–552PubMedCrossRef Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN (2013) Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics 33(2):535–552PubMedCrossRef
31.
go back to reference Fry AC, Singh S, Gunda SS, Boustead GB, Hanbury DC, McNicholas TA et al (2008) Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 108:213–220CrossRef Fry AC, Singh S, Gunda SS, Boustead GB, Hanbury DC, McNicholas TA et al (2008) Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 108:213–220CrossRef
32.
go back to reference van Bommel EF, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49:615–625PubMedCrossRef van Bommel EF, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49:615–625PubMedCrossRef
33.
go back to reference Ilie CP, Pemberton RJ, Tolley DA (2006) Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment. BJU Int 98:137–140PubMedCrossRef Ilie CP, Pemberton RJ, Tolley DA (2006) Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment. BJU Int 98:137–140PubMedCrossRef
34.
go back to reference Heidenreich A, Derakhshani P, Neubauer S, Krug B (2009) Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urology 39:141–148CrossRef Heidenreich A, Derakhshani P, Neubauer S, Krug B (2009) Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urology 39:141–148CrossRef
35.
go back to reference Harreby M, Bilde T, Helin P, Meyhoff HH, Vinterberg H, Nielsen VA (1994) Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol 28:237–242PubMed Harreby M, Bilde T, Helin P, Meyhoff HH, Vinterberg H, Nielsen VA (1994) Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol 28:237–242PubMed
36.
go back to reference Adler S, Lodermeyer S, Gaa J, Heemann U (2008) Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 47:1535–1538CrossRef Adler S, Lodermeyer S, Gaa J, Heemann U (2008) Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 47:1535–1538CrossRef
37.
go back to reference van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG (2006) Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 144:101–106PubMedCrossRef van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG (2006) Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 144:101–106PubMedCrossRef
38.
go back to reference Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R et al (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378:338–346PubMedCrossRef Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R et al (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378:338–346PubMedCrossRef
39.
go back to reference Fernández-Codina A, Martínez-Valle F, Castro-Marrero J, Detorres I, Vilardell-Tarrés M, Ordi-Ros J (2013) Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol 32(6):889–893PubMedCrossRef Fernández-Codina A, Martínez-Valle F, Castro-Marrero J, Detorres I, Vilardell-Tarrés M, Ordi-Ros J (2013) Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol 32(6):889–893PubMedCrossRef
40.
go back to reference Alberici F, Palmisano A, Urban ML, Maritati F, Oliva E, Manenti L, et al (2013) Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 72(9):1584–1586 Alberici F, Palmisano A, Urban ML, Maritati F, Oliva E, Manenti L, et al (2013)  Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 72(9):1584–1586
Metadata
Title
Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature
Authors
Hang Liu
Gejun Zhang
Yimeng Niu
Nan Jiang
Weiguo Xiao
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3002-6

Other articles of this Issue 12/2014

Rheumatology International 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine